RxDoctor Payments DataLook up a doctor →

Tolga Suvar

Anesthesiology · Chicago, ILNPI 1861887291

Payments from drug & device makers

$369,514in general payments, 2019–2025

Across 934 payments — averaging $395.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$82K
  • Abbott$79K
  • Boston Scientific$58K
  • Nalu Medical, Inc.$31K
  • Globus Medical$29K
  • Nevro Corp.$26K
  • plus $65K from 22 others
$1,025in research payments, 2019–2025

Across 1 payment — averaging $1025.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1K

What the payments were for

  • Consulting fees$63,64221%
  • Speaking & faculty fees$169,36556%
  • Grants$530%
  • Travel & lodging$27,2109%
  • Food & beverage$38,73213%
  • Education$3,5851%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$369,514 in reported general payments places this provider in the 95th percentile of 1,980 anesthesiology providers in Illinois.

See all anesthesiology providers in Illinois

Medicare billing

Part B allowed, 2024
$190,871
Medicare patients
473
Services billed
2,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl13$14,653
BelbucaBuprenorphine Hcl11$8,089
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen286$6,275
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$2,676
Pregabalin174$2,433
Gabapentin167$2,091
Lidocaine24$1,950
Tizanidine Hcl116$1,917
Tramadol Hcl189$1,490
Celecoxib54$1,486
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen56$1,383
Oxycodone Hcl71$1,319
Naloxone Hcl19$1,307
Baclofen79$1,143
Cyclobenzaprine Hcl54$1,077

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →